Announcements Trials
Browse Landscape

Phase

Phase NA 6

Status

Completed 6Unknown 3Recruiting 2Not yet recruiting 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 6Observational 4

Sponsor

Conditions

Leiomyoma 5Myoma 3Menorrhagia 3Polyps 1Myofibroma 1Agnosia 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Interventional × Uterine Myomectomy × Clear all
NCT02577055 2025-11-20

Lune2

Assistance Publique - Hôpitaux de Paris

Phase NA Completed
9 enrolled

Leiomyoma

NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed
114 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT02563392 2024-08-13

ORAM

University Hospital, Geneva

Phase NA Completed
58 enrolled

Myofibroma

NCT01563783 2023-02-01

TRUST

Acessa Health, Inc.

Phase NA Completed
84 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT01750008 2018-11-20

LUSTOR

Acessa Health, Inc.

Phase NA Completed
51 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT01152112 2017-09-13

HOME

Hologic, Inc.

Phase NA Completed
74 enrolled 5 charts

Agnosia, Leiomyoma, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡